Table 3.
Months 0–1 |
Months 2–3 |
Months 4–6 |
||||
---|---|---|---|---|---|---|
Miln (mg/day) | Met (mg/day) | Miln (mg/day) | Met (mg/day) | Miln (mg/day) | Met (mg/day) | |
Responders (n = 46) | 43 | 1264 | 72 | 1674 | 81 | 1737 |
Non-responders (n = 12) | 46 | 1563 | 56 | 1700 | 58* | 1742 |
p < 0.05.
Abbreviations: Miln, milnacipran; Met, metformin.